A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure
- Author
- M LAMOTTE, Lieven Annemans (UGent) and B SCHOCKAERT
- Organization
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-350705
- MLA
- LAMOTTE, M., et al. “A Cost-Effectiveness Analysis of Candesartan in the Treatment of Chronic Heart Failure.” VALUE IN HEALTH, vol. 8, no. 6, BLACKWELL PUBLISHING, 2005, p. 3.
- APA
- LAMOTTE, M., Annemans, L., & SCHOCKAERT, B. (2005). A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure. VALUE IN HEALTH, 8(6), 3. BLACKWELL PUBLISHING.
- Chicago author-date
- LAMOTTE, M, Lieven Annemans, and B SCHOCKAERT. 2005. “A Cost-Effectiveness Analysis of Candesartan in the Treatment of Chronic Heart Failure.” In VALUE IN HEALTH, 8:3. BLACKWELL PUBLISHING.
- Chicago author-date (all authors)
- LAMOTTE, M, Lieven Annemans, and B SCHOCKAERT. 2005. “A Cost-Effectiveness Analysis of Candesartan in the Treatment of Chronic Heart Failure.” In VALUE IN HEALTH, 8:3. BLACKWELL PUBLISHING.
- Vancouver
- 1.LAMOTTE M, Annemans L, SCHOCKAERT B. A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure. In: VALUE IN HEALTH. BLACKWELL PUBLISHING; 2005. p. 3.
- IEEE
- [1]M. LAMOTTE, L. Annemans, and B. SCHOCKAERT, “A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure,” in VALUE IN HEALTH, 2005, vol. 8, no. 6, p. 3.
@inproceedings{350705, author = {{LAMOTTE, M and Annemans, Lieven and SCHOCKAERT, B}}, booktitle = {{VALUE IN HEALTH}}, issn = {{1098-3015}}, language = {{und}}, number = {{6}}, pages = {{A3-A3}}, publisher = {{BLACKWELL PUBLISHING}}, title = {{A cost-effectiveness analysis of candesartan in the treatment of chronic heart failure}}, volume = {{8}}, year = {{2005}}, }